In other words, a decrease of the II, as observed for instance in diabetic MetS patients, does not inform on the question whether the impaired release of insulin is attributable to an alteration of the process of glucose recognition by the B cells as an insulinotropic agent, a decreased availability of insulin in the pancreatic gland or a combination of the latter two processes [35,46,47]. Here, INS is linked to metabolic syndrome.